Charles River Associates (CRA) Bolsters Life Sciences Practice with Appointment of Christopher Zealey as Vice President
Business Wire•06/10/2026•08:30 ET
0
Key Highlights
- ➤CRA (CRAI) appointed Christopher Zealey vice president in its Life Sciences Practice
- ➤Zealey brings medical affairs, launch strategy, and clinical positioning expertise to CRA
- ➤CRA is expanding Life Sciences capabilities amid increasingly complex medical affairs decisions
- ➤Zealey previously led consulting engagements supporting product launches and in-line asset strategies
Expert Statements
Paul Maleh, President and Chief Executive Officer of Charles River Associates
“I am pleased to welcome Chris to CRA. His areas of expertise include cross functional and medical strategic and tactical planning, insight generation, scientific communication strategy, and clinical positioning. He joins a team dedicated to addressing CRA’s life sciences clients’ most complex business challenges.”
Dr. Gregory K. Bell, CRA Group Vice President and Life Sciences Practice Leader
“Chris has an impressive track record of supporting medical affairs clients using clinical, stakeholder, and market insights to form actionable and measurable strategies. We look forward to working with Chris during an exciting period of growth and opportunity for our Practice and the broader industry. As clients face increasingly complex medical affairs and launch decisions, Chris's experience leveraging data, evidence, and stakeholder perspectives to inform strategy will further strengthen the value we bring to life sciences organizations.”
Charles River Associates (CRA) Bolsters Life Sciences Practice with Appointment of Christopher Zealey as Vice President
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced the appointment of Christopher Zealey as a Vice President in the firm’s Life Sciences Practice .
Get started
Create a free account to read the full story.